p.boateng
TL2 Moderator · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 11 December 2024 · last posted 18h
96 posts, newest first. Showing up to 150.
-
About the HPLC & UHPLC category Replied, post #5 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 0 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Peer-to-peer review: what actually happens on the call Replied, post #3 · Access › Insurance & coverage · 27 Jul 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #37 · Practice › Interactions · 17 Jul 2026 · 17 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #49 · Evidence › Trials · 17 Jul 2026 · 2 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Transit times by route, from a logged dataset Replied, post #11 · Sourcing › Logistics · 15 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Common supplements people ask about, assessed one at a time Replied, post #45 · Practice › Interactions · 14 Jul 2026 · 7 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #19 · Sourcing › Regulatory · 14 Jul 2026 · 18 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Pages past their review date, listed — does this still hold? Replied, post #39 · Meta › Wiki maintenance · 5 Jul 2026 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Redundancy: if two maintained pages cover largely the same ground, consolidation…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #45 · Clinical › Comorbidities · 24 Jun 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pooling trials with different estimands Replied, post #39 · Evidence › Meta-analyses · 21 Jun 2026 · 13 likes I read post #37 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #45 · Analytics › HPLC & UHPLC · 18 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Comparing documentation quality across the directory, tabulated Replied, post #6 · Sourcing › Vendor reports · 16 Jun 2026 · 25 likes This follows post #3 rather than contradicting it. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity.…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #29 · Evidence › Journal club · 11 Jun 2026 · 24 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Alcohol: what is documented and what is folklore Replied, post #49 · Practice › Interactions · 9 Jun 2026 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #13 · Start Here › Welcome · 9 Jun 2026 · 4 likes On post #9 — agreed on the reasoning, with one qualification. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #74 · Practice › Storage & stability · 2 Jun 2026 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #10 · Analytics › HPLC & UHPLC · 30 May 2026 · 7 likes Coming back to post #8, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Revisiting: Body image changing more slowly than the body Replied, post #5 · Wellbeing › Mental health · 20 May 2026 · 16 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading a trial's population section before its results Replied, post #35 · Evidence › Trials · 19 May 2026 · 16 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #31 · Practice › Storage & stability · 17 May 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #47 · Practice › Reconstitution · 15 May 2026 · 10 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #13 · Start Here › Welcome · 9 May 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #38 · Outcomes › Progress reports · 29 Apr 2026 · 0 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Journal club: is percentage weight change the right endpoint? Replied, post #99 · Evidence › Journal club · 24 Apr 2026 · 5 likes post #98 is right about the mechanism and I think understates the practical bit. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #11 · Compounds › Oral incretins · 23 Apr 2026 · 18 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Does a peptide degrade silently, with no visual change? Replied, post #12 · Practice › Storage & stability · 18 Apr 2026 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
List price versus negotiated price versus what you pay Replied, post #48 · Access › Pricing · 12 Apr 2026 · 11 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
Choosing which test to pay for, given a fixed budget Replied, post #51 · Sourcing › Independent verification · 2 Apr 2026 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Grapefruit: why this class is not the class that cares Replied, post #63 · Practice › Interactions · 21 Mar 2026 · 0 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Cost per delivered dose, which is the number that matters Replied, post #59 · Access › Pricing · 21 Mar 2026 · 8 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #66 · Compounds › Repair & healing peptides · 14 Mar 2026 · 7 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
Forced degradation studies: designing one that is informative Replied, post #16 · Analytics › Method validation · 7 Mar 2026 · 30 likes Picking up post #13: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #20 · Research Methods › N-of-1 designs · 27 Feb 2026 · 20 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #33 · Research Methods › N-of-1 designs · 18 Feb 2026 · 1 like Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #12 · Compounds › Tirzepatide · 10 Feb 2026 · 5 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #21 · Outcomes › Body composition · 1 Feb 2026 · 12 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #26 · Data & Tools › Calculators · 19 Jan 2026 · 2 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
Aggregates and why a purity assay may miss them entirely Replied, post #41 · Analytics › Impurities & related substances · 31 Dec 2025 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Filter needles: when they help and what they cost you Replied, post #8 · Devices › Syringes & needles · 20 Dec 2025 · 16 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #20 · Sourcing › Red flags · 19 Dec 2025 · 0 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
What I would record differently if I started again — the long version Replied, post #20 · Outcomes › Progress reports · 17 Dec 2025 · 31 likes Worth separating two things that post #16 runs together. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the…
-
Amylin receptor signalling and satiety — what changed since Replied, post #5 · Pharmacology › Receptor biology · 16 Dec 2025 · 19 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Waist circumference technique and its repeatability Replied, post #22 · Outcomes › Progress reports · 1 Dec 2025 · 2 likes This follows post #19 rather than contradicting it. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #32 · Sourcing › Regulatory · 14 Nov 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #120 · Practice › Storage & stability · 4 Nov 2025 · 31 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
EU-wide position versus national implementation — what changed since Replied, post #4 · Regional › European Union · 6 Oct 2025 · 5 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
The headache that turns out to be dehydration Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 26 Sep 2025 · 0 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #128 · Evidence › Study critique · 16 Sep 2025 · 6 likes Worth separating two things that post #124 runs together. Confounding: in observational data, is there a third variable that explains the apparent association? In…
-
Documentation that appears only after payment Replied, post #17 · Sourcing › Red flags · 3 Sep 2025 · 13 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Follow-up: Why appetite effects are mostly central Replied, post #31 · Pharmacology › Receptor biology · 2 Sep 2025 · 12 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Guidelines revision: what changed and why — one year on Replied, post #12 · Meta › Announcements · 1 Sep 2025 · 0 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #53 · Practice › Dosing & titration · 29 Aug 2025 · 4 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #81 · Evidence › Journal club · 21 Aug 2025 · 16 likes post #80 answers the question as asked. The question underneath it is different. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Are there stupid questions here? A staff answer, at length Replied, post #34 · Start Here › Welcome · 2 Aug 2025 · 11 likes Worth separating two things that post #30 runs together. The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you…
-
Second pass at: Sleep tracking data and its considerable limitations Replied, post #3 · Wellbeing › Sleep · 1 Aug 2025 · 0 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
How to research a compound with no human data without deceiving yourself Replied, post #40 · Compounds › Other compounds · 1 Aug 2025 · 0 likes Picking up post #37: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #29 · Compounds › Secretagogues & GH axis · 27 Jul 2025 · 24 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #83 · Compounds › Semaglutide · 23 Jul 2025 · 6 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #57 · Sourcing › Regulatory · 22 Jul 2025 · 2 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #84 · Evidence › Trials · 22 Jul 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #67 · Compounds › Oral incretins · 20 Jul 2025 · 31 likes Picking up post #64: that is the part I would want checked first. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
-
What this community means by "a source", in practical terms Replied, post #40 · Start Here › Welcome · 19 Jul 2025 · 1 like Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #13 · Compounds › Oral incretins · 29 Jun 2025 · 21 likes post #12 answers the question as asked. The question underneath it is different. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple…
-
Needle changes between doses on a reusable pen Replied, post #16 · Devices › Pens & autoinjectors · 23 Jun 2025 · 21 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
Why plausible mechanism is not evidence of effect Replied, post #16 · Compounds › Repair & healing peptides · 17 Jun 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Half-life, steady state, and accumulation worked through Replied, post #67 · Pharmacology › Pharmacokinetics · 5 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #7 · Access › Insurance & coverage · 4 Jun 2025 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #17 · Compounds › Repair & healing peptides · 18 May 2025 · 0 likes Picking up post #14: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
A well-designed study with a badly written abstract Replied, post #88 · Evidence › Study critique · 17 May 2025 · 0 likes I read post #86 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #26 · Evidence › Journal club · 18 Apr 2025 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
A supplier that answers analytical questions with restated claims Replied, post #55 · Sourcing › Red flags · 11 Apr 2025 · 1 like Worth separating two things that post #51 runs together. Patterns that reliably precede a problem: underdosing (less active material than stated, documented by…
-
Carryover and the ghost peak from last week's standard Started this topic · Analytics › HPLC & UHPLC · 30 Mar 2025 · 21 likes On the subject in the title: Carryover and the ghost peak from last week's standard Working notes rather than a conclusion. Posting the method first, because I know…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 4 likes This follows the opening post rather than contradicting it. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #19 · Sourcing › Vendor reports · 15 Mar 2025 · 7 likes This follows post #16 rather than contradicting it. Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows…
-
Validating a method you did not develop — does this still hold? Replied, post #61 · Analytics › Method validation · 1 Mar 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #3 · Evidence › Trials · 27 Feb 2025 · 26 likes Worth separating two things that the opening post runs together. Confounding in observational data: a third variable can explain an apparent association. In a…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #12 · Compounds › Semaglutide · 15 Feb 2025 · 19 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #60 · Sourcing › Regulatory · 9 Jan 2025 · 13 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Converting between mg/mL and units per dose, both directions Replied, post #130 · Practice › Reconstitution · 14 Dec 2024 · 2 likes Picking up post #127: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Two sessions a week versus four: what the evidence supports Replied, post #19 · Nutrition & Training › Resistance training · 30 Nov 2024 · 24 likes Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…
-
[2026 update] New subcategory: rationale and scope Replied, post #31 · Meta › Announcements · 29 Nov 2024 · 28 likes post #30 is right about the mechanism and I think understates the practical bit. Implementation timeline: announcements include when a change takes effect. Marking the…
-
Washout with a one-week half-life: the arithmetic Replied, post #3 · Research Methods › N-of-1 designs · 21 Nov 2024 · 5 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #27 · Practice › Interactions · 16 Nov 2024 · 20 likes post #26 answers the question as asked. The question underneath it is different. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E,…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #53 · Clinical › Prescriber conversations · 12 Nov 2024 · 6 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Revisiting: Moderation log format change Replied, post #13 · Meta › Announcements · 1 Nov 2024 · 30 likes This follows post #10 rather than contradicting it. Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #4 · Compounds › Oral incretins · 4 Oct 2024 · 33 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #66 · Clinical › Bloodwork · 29 Sep 2024 · 13 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #47 · Compounds › Retatrutide · 19 Sep 2024 · 0 likes This follows post #44 rather than contradicting it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #40 · Sourcing › Independent verification · 6 Sep 2024 · 17 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Revisiting: Five questions in one post gets you one answer — how to split them Replied, post #2 · Start Here › How to Ask · 31 Aug 2024 · 28 likes the opening post answers the question as asked. The question underneath it is different. Questions you cannot explain: "I cannot say why I am asking this, but is this…
-
A rising related-substance total over six months: degradation or method drift? Started this topic · Analytics › Impurities & related substances · 21 Aug 2024 · 3 likes Asking directly, because I could not find a straight answer: A rising related-substance total over six months: degradation or method drift? Posting the method first,…
-
How to ask for a dose change without antagonising anyone Replied, post #13 · Clinical › Prescriber conversations · 10 Aug 2024 · 4 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Promotion criteria, and the one that stops most nominations Replied, post #33 · Documentation › Doc review · 7 Aug 2024 · 22 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #69 · Compounds › Retatrutide · 21 Jul 2024 · 4 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Assessing a warm arrival: the decision process — one year on Replied, post #115 · Sourcing › Logistics · 1 Jun 2024 · 14 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Tracking a preprint to publication: a worked example — the long version Started this topic · Evidence › Preprints · 13 May 2024 · 0 likes Posting this under the heading it deserves: Tracking a preprint to publication: a worked example — the long version Everything below is what sits behind that. Comparing…